课题基金 / 基金详情

项目摘要

项目成果

DAVID A WILLIAMS的其他基金

相似基金

相关文献

中文摘要
翻译
(请保持文字,不要PDF) 标题:Septin 6组在小鼠和人造血中的作用 1 R01 DK137172-01 隔膜蛋白是高度保守的GT3蛋白,其调节多种细胞功能,包括胞质分裂、极性、细胞周期、囊泡运输、胞吐作用和扩散屏障的产生。我们最近发现了一名患有严重中性粒细胞减少症的非综合征新生儿(Renella,AJH 2022),该新生儿在SEPTIN 6基因的C端存在一种新的X连锁生殖系突变(SEPTIN 6 c.1282T>C p.428Glnext*9),与骨髓生成障碍相关。将生殖系突变编辑为正常男性CD 34+造血干细胞和祖细胞(HSC/P)表型模仿了临床综合征的关键病理特征,包括大的多核核细胞核和体外髓系祖细胞生长减少(初步数据)。已经提出C-末端在细丝稳定、成束和弯曲以及与其他septins的相互作用中起关键作用,并且计算机模拟表明,添加与SEPTIN 6 c.1282T>C p.428Glnext*9突变相关的9个氨基酸(aa)将通过干扰SEPTIN 6蛋白相互作用来改变功能。基于我们的首次发表,在西雅图发现了第二例重度中性粒细胞减少症患者,该患者在同一密码子中存在不同突变(SEPTIN 6 c.1282 T>A)(Mohamad,Allensbach,威廉姆斯,接受报告,ASH 2022)。虽然氨基酸取代不同,但建模预测SEPTIN 6变体采用相同的结构。这两个确定的患者有高度的骨髓四倍体的骨髓和难治性G-CSF。
英文摘要
(PLEASE KEEP IN WORD, DO NOT PDF) Title: The role of Septin6 Group in Murine and Human Hematopoiesis 1 R01 DK137172-01 Septins are highly conserved GTPase proteins which regulate a variety of cellular functions including cytokinesis, polarity, cell cycle, vesicle trafficking, exocytosis, and creation of diffusion barriers. We have recently identified a non-syndromic newborn with severe neutropenia (Renella, AJH 2022) with a novel X-linked germline mutation in the C-terminus of SEPTIN6 gene (SEPTIN6 c.1282T>C p.428Glnext*9) associated with dysmyelopoiesis. Editing the germline mutation into normal male CD34+ hematopoietic stem and progenitor cells (HSC/P) phenocopied key pathologic features of the clinical syndrome, including large, multinucleated nuclei and reduced myeloid progenitor growth in vitro (preliminary data). The C-terminus has been proposed to play a key role in filament stabilization, bundling and bending as well as interactions with other septins and in silico modeling suggest the addition of 9 amino acids (aa) associated with the SEPTIN6 c.1282T>C p.428Glnext*9 mutation would alter function by interfering with SEPTIN6 protein interactions. Based on our initial publication, a second patient with severe neutropenia has since been identified in Seattle with a distinct mutation in the same codon (SEPTIN6 c.1282T>A) (Mohamad, Allensbach, Williams, accepted for presentation, ASH 2022). While the aa substitution is different, modeling predicts that SEPTIN6 variants adopt the same structure. Both identified patients had a high degree of myeloid tetraploidy in the marrow and were refractory to G-CSF.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease
  • 批准号:
    10083551
  • 项目类别:
  • 资助金额:
    $120.04万
  • 财政年份:
    2020
  • 负责人:
    DAVID A WILLIAMS
  • 依托单位:
Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease
  • 批准号:
    10179447
  • 项目类别:
  • 资助金额:
    $19.68万
  • 财政年份:
    2017
  • 负责人:
    DAVID A WILLIAMS
  • 依托单位:
Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease
  • 批准号:
    9363943
  • 项目类别:
  • 资助金额:
    $167.34万
  • 财政年份:
    2017
  • 负责人:
    DAVID A WILLIAMS
  • 依托单位:
ConProject-005
  • 批准号:
    10594167
  • 项目类别:
  • 资助金额:
    $7.42万
  • 财政年份:
    2016
  • 负责人:
    DAVID A WILLIAMS
  • 依托单位:
海外基金